Editas Medicine, Inc. - Common Stock (EDIT)

Historical Holders from Q1 2016 to Q3 2025

Symbol
EDIT on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
82.8M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
43.1M
Holdings value
$149M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
189
Number of buys
69
Number of sells
-80
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Editas Medicine, Inc. - Common Stock (EDIT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.9% $10.5M 6.54M BlackRock, Inc. 31 Mar 2025

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 43.1M $149M +$7.92M $3.47 189
2025 Q2 41.3M $91M -$2.65M $2.20 190
2025 Q1 44M $51.1M -$8.64M $1.16 189
2024 Q4 51.1M $64.8M -$27M $1.27 199
2024 Q3 55M $188M -$7.61M $3.41 223
2024 Q2 56.4M $263M -$55.7M $4.67 229
2024 Q1 67.9M $504M +$62.9M $7.42 221
2023 Q4 58.8M $596M -$24.8M $10.13 222
2023 Q3 61.7M $481M -$15.3M $7.80 220
2023 Q2 62.8M $517M +$83.1M $8.23 234
2023 Q1 53M $384M -$13.7M $7.25 231
2022 Q4 54.1M $480M +$43.3M $8.87 245
2022 Q3 48.3M $591M +$8.78M $12.24 243
2022 Q2 47.5M $561M +$5.83M $11.83 235
2022 Q1 45.4M $862M -$137M $19.02 239
2021 Q4 50.9M $1.35B -$58.1M $26.55 288
2021 Q3 51.7M $2.12B -$9.9M $41.08 307
2021 Q2 52.1M $2.96B -$42.3M $56.64 309
2021 Q1 53.1M $2.23B -$37M $42.00 296
2020 Q4 52.9M $3.71B -$146M $70.11 303
2020 Q3 55.2M $1.55B +$16M $28.06 233
2020 Q2 54.2M $1.6B +$264M $29.58 225
2020 Q1 45.6M $905M -$9.12M $19.83 186
2019 Q4 45.8M $1.36B +$25.8M $29.61 221
2019 Q3 45M $1.02B +$118M $22.74 180
2019 Q2 39.8M $983M +$65.9M $24.74 187
2019 Q1 37.5M $916M +$73.8M $24.45 194
2018 Q4 34.5M $784M +$24.2M $22.75 187
2018 Q3 33.2M $1.06B +$32.9M $31.82 192
2018 Q2 32.1M $1.15B +$38.2M $35.83 208
2018 Q1 31.2M $1.03B +$26M $33.15 192
2017 Q4 30.4M $934M +$80.8M $30.73 146
2017 Q3 27.4M $657M +$43.9M $24.01 115
2017 Q2 25.8M $434M +$21.3M $16.78 107
2017 Q1 27.5M $614M +$121M $22.32 99
2016 Q4 23.5M $381M +$21.3M $16.23 84
2016 Q3 22.2M $299M +$9.01M $13.48 71
2016 Q2 17.6M $429M -$15.1M $24.40 64
2016 Q1 18.2M $625M +$464M $34.54 48